Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Enterprise Value (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Enterprise Value data on record, last reported at -$180.2 million in Q3 2025.

  • For Q3 2025, Enterprise Value rose 44.89% year-over-year to -$180.2 million; the TTM value through Sep 2025 reached -$180.2 million, up 44.89%, while the annual FY2024 figure was -$294.5 million, 1.73% down from the prior year.
  • Enterprise Value reached -$180.2 million in Q3 2025 per GOSS's latest filing, up from -$212.9 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$19.1 million in Q1 2022 and bottomed at -$354.5 million in Q2 2024.
  • Average Enterprise Value over 4 years is -$213.0 million, with a median of -$238.3 million recorded in 2024.
  • Peak YoY movement for Enterprise Value: plummeted 958.83% in 2023, then soared 44.89% in 2025.
  • A 4-year view of Enterprise Value shows it stood at -$255.7 million in 2022, then fell by 13.23% to -$289.5 million in 2023, then fell by 1.73% to -$294.5 million in 2024, then surged by 38.81% to -$180.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$180.2 million in Q3 2025, -$212.9 million in Q2 2025, and -$257.9 million in Q1 2025.